Efzofitimod for pulmonary sarcoidosis showed clinical benefits despite missing its primary endpoint. More patients stopped steroids and improved quality of life. It was well-tolerated, maintaining lung function. aTyr Pharma will now discuss these results with the FDA.
The FDA criticized Hims & Hers' Super Bowl ad for weight-loss drugs, saying it broke federal law by showing only benefits, not risks. The agency is now boosting enforcement on misleading drug ads, especially for online pharmacies and compounded drugs.
Ocugen partnered with Kwangdong to bring OCU400, a potential one-time gene therapy for RP blindness, to Korea. This could help 7,000 patients and brings Ocugen up to $7.5M upfront + royalties.
Trump officials plan to link COVID vaccines to 25 child deaths using unverified VAERS data. This news dropped vaccine makers' shares. HHS calls it "pure speculation", while Moderna states its vaccine is rigorously monitored with no new safety concerns.
Apple Watch now has an FDA-approved feature to detect high blood pressure! It uses your heart sensor over 30 days to spot signs of hypertension, then tells you to see a doctor. Available next week on Series 9-11/Ultra 2-3, helping you catch a serious health risk early.
Cocrystal's CDI-988 is a new oral drug that may prevent/treat norovirus, the stomach bug. It targets a viral enzyme, shows broad-spectrum activity & good safety in early studies. FDA approved next study for this potential first-of-its-kind antiviral.
